SCHEMBL8469858

SCHEMBL8469858

COc1ccc(-c2cccc(OC(C)=O)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.60
GAA P10253 1/20 0.60
BACE1 P56817 3/20 0.60
MAPT P10636 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
ABL1 P00519 1/20 0.59
ABCB1 P08183 1/20 0.59
BCR P11274 1/20 0.59
GAPDH P04406 2/20 0.55
HDAC4 P56524 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
CYP3A4 P08684 1/20 0.54
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
PKM P14618 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HPGD P15428 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8469479 0.93 LMNA (0.65) LMNAGAABACE1MAPTTDP1
SCHEMBL26009136 0.91 LMNA (0.59) LMNAGAABACE1MAPTTDP1
SCHEMBL4607313 0.91 LMNA (0.71) LMNAGAAMAPTTDP1GAPDH
SCHEMBL8678710 0.90 ABL1 (0.59) LMNAGAABACE1MAPTTDP1
SCHEMBL28032593 0.89 LMNA (0.66) LMNAGAABACE1MAPTTDP1
SCHEMBL4446422 0.86 MAPT (0.67) LMNAGAABACE1MAPTTDP1
SCHEMBL8523753 0.85 CYP3A4 (0.66) LMNAGAAMAPTTDP1ABL1
SCHEMBL28743154 0.85 LMNA (0.66) LMNAGAAMAPTTDP1GAPDH
SCHEMBL2608606 0.84 HSD17B10 (0.66) LMNAGAABACE1MAPTTDP1
SCHEMBL14700512 0.84 HSD17B10 (0.66) LMNAGAABACE1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999025707-A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME ELI LILLY AND COMPANY (US) 1999-05-27 WO claimed